A phase IV open-label study of predictive markers in Growth Hormone Deficient and Turner Syndrome pre-pubertal children treated with SAIZEN.
100 Clinical Results associated with Industria Farmaceutica Serono
0 Patents (Medical) associated with Industria Farmaceutica Serono
100 Deals associated with Industria Farmaceutica Serono
100 Translational Medicine associated with Industria Farmaceutica Serono